SPA: A Quantitation Strategy for MS Data in Patient-derived Xenograft Models

With the development of mass spectrometry (MS)-based proteomics technologies, patient-derived xenograft (PDX), which is generated from the primary tumor of a patient, is widely used for the proteome-wide analysis of cancer mechanism and biomarker identification of a drug. However, the proteomics dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xi, Qian, Lili, Wang, Bo, Tan, Minjia, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040016/
https://www.ncbi.nlm.nih.gov/pubmed/33631430
http://dx.doi.org/10.1016/j.gpb.2019.11.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040016/
https://www.ncbi.nlm.nih.gov/pubmed/33631430
http://dx.doi.org/10.1016/j.gpb.2019.11.016

Ejemplares similares